Horm Metab Res 2015; 47(08): 596-599
DOI: 10.1055/s-0034-1389957
Endocrine Research
© Georg Thieme Verlag KG Stuttgart · New York

Expression of Corticosteroid-Binding Globulin CBG in the Human Heart

H. H. Schäfer
1   Institute of Anatomy II, University Hospital Jena, Friedrich Schiller University, Jena, Germany
,
V. M. Gebhart
1   Institute of Anatomy II, University Hospital Jena, Friedrich Schiller University, Jena, Germany
,
K. Hertel
2   Institute of Pathology, HELIOS Klinikum Erfurt, Erfurt, Germany
,
G. F. Jirikowski
1   Institute of Anatomy II, University Hospital Jena, Friedrich Schiller University, Jena, Germany
› Author Affiliations
Further Information

Publication History

received 07 July 2014

accepted 26 August 2014

Publication Date:
24 September 2014 (online)

Abstract

Glucocorticoids are known to be involved in myocardial regeneration and destruction. Cardiomyocytes are mostly devoid of nuclear glucocorticoid receptors (GRs) and it is generally assumed that effects of adrenal steroids in heart are mediated through the mineralocorticoid receptor (MR). Here we used immunocytochemistry to study localization of corticosteroid binding globulin (CBG) in semithin sections of human cardiac tissue samples. With staining of consecutive sections we examined colocalization with GR and MR immunoreactivities. While GR staining was almost undetectable, a portion of myocytes with MR immunostained nuclei was found. Almost all cardiomyocytes exhibited CBG immunostaining in cytoplasm and on the cell membrane. Most pronounced CBG immunoreactivities were found in Purkinje fibers and in smooth muscle cells of arterial walls. With RT-PCR, we found in homogenates of cardiac tissue detectable levels of CBG encoding mRNA. Our findings indicate that CBG is expressed in human heart. Known cardiac effects of adrenal steroids may in part be mediated through the binding globulin and its putative membrane receptor in addition to nuclear steroid receptors and direct genomic action. Highlights of our study: Human cardiomyocytes express mineralocorticoid receptors, but are mostly free of nuclear glucocorticoid receptors. CBG is expressed in myocardium and in Purkinje fibers. CBG in heart is colocalized with mineralocorticoid receptor. Endothelia and smooth muscle cells of arterial walls show colocalization of CBG and MR.

 
  • References

  • 1 Niebylski A, Boccolini A, Bensi N, Binotti S, Hansen C, Yaciuk R, Gauna H. Neuroendocrine Changes and Natriuresis in Response to Social Stress in Rats. Stress Health 2012; 28: 179-185
  • 2 Lumbers ER, Boyce AC, Joulianos G, Kumarasamy V, Barner E, Segar JL, Burrell JH. Effects of cortisol on cardiac myocytes and on expression of cardiac genes in fetal sheep. Am J Physiol Regul Int Comp Physiol 2005; 288: R567-R574
  • 3 Fuller PJ, Yao Y, Yang J, Young MJ. Mechanisms of ligand specificity of the mineralocorticoid receptor. J Endocrinol 2012; 213: 15-24
  • 4 Baxter JD, Funder JW, Apriletti JW, Webb P. Towards selectively modulating mineralocorticoid receptor function: lessons from other systems. Mol Cell Endocrinol 2004; 217: 151-165
  • 5 Reynolds RM, Walker BR, Haw S, Newby DE, Mackay DF, Cobbe SM, Pell AC, Fischbacher C, Pringle S, Murdoch D, Dunn F, Oldroyd K, Macintyre P, O’Rourke B, Pell JP. Low serum cortisol predicts early death after acute myocardial infarction. Crit Care Med 2010; 38: 973-975
  • 6 Norasyikin AW, Norlela S, Rozita M, Masliza M, Shamsul AS, Nor Azmi K. Adrenal insufficiency in acute coronary syndrome. Singapore Med J 2009; 50: 962-966
  • 7 Yamaji M, Tsutamoto T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M, Horie M. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress. Circ Heart Failure 2009; 2: 608-615
  • 8 Mihailidou AS, Loan Le TY, Mardini M, Funder JW. Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 2009; 54: 1306-1312
  • 9 Weir RA, Tsorlalis IK, Steedman T, Dargie HJ, Fraser R, McMurray JJ, Connell JM. Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction. Eur J Heart Failure 2011; 13: 1305-1313
  • 10 Lother A, Berger S, Gilsbach R, Rosner S, Ecke A, Barreto F, Bauersachs J, Schutz G, Hein L. Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function. Hypertension 2011; 57: 746-754
  • 11 Hammond GL. Molecular properties of corticosteroid binding globulin and the sex-steroid binding proteins. Endocrine Rev 1990; 11: 65-79
  • 12 Scrocchi LA, Hearn SA, Han VK, Hammond GL. Corticosteroid-binding globulin biosynthesis in the mouse liver and kidney during postnatal development. Endocrinology 1993; 132: 910-916
  • 13 Schock HW, Herbert Z, Sigusch H, Figulla HR, Jirikowski GF, Lotze U. Expression of androgen-binding protein (ABP) in human cardiac myocytes. Horm Metab Res 2006; 38: 225-229
  • 14 Sivukhina EV, Jirikowski GF. Adrenal steroids in the brain: role of the intrinsic expression of corticosteroid-binding globulin (CBG) in the stress response. Steroids 2014; 81: 70-73
  • 15 Nader N, Raverot G, Emptoz-Bonneton A, Dechaud H, Bonnay M, Baudin E, Pugeat M. Mitotane has an estrogenic effect on sex hormone binding globulin and corticosteroid binding globulin in humans. J Clin Endocrinol Metab 2006; 91: 2165-2170
  • 16 Kuhn RW, Green AL, Raymoure WJ, Siiteri PK. Immunocytochemical localization of corticosteroid-binding globulin in rat tissues. J Endocrinol 1986; 108: 31-36
  • 17 Iqbal J, Andrew R, Cruden NL, Kenyon CJ, Hughes KA, Newby DE, Hadoke PW, Walker BR. Displacement of cortisol from human heart by acute administration of a mineralocorticoid receptor antagonist. J Clin Endocrinol Metab 2014; 99: 915-922
  • 18 Baxter JD, Funder JW, Apriletti JW, Webb P. Towards selectively modulating mineralocorticoid receptor function: lessons from other systems. Mol Cell Endocrinol 2004; 217: 151-165
  • 19 Coons JC, Barnes M, Kusick K. Takotsubo cardiomyopathy. Am J Health Syst Pharm 2009; 66: 562-566
  • 20 Sorensen MV, Praetorius HA, Nykjaer A, Willnow T, Leipziger J. Impaired aldosterone responsiveness in corticosteroid binding globulin deficient mice. Acta Physiol (Oxf) 2011; 201: 169-177
  • 21 Lazzarino AI, Hamer M, Gaze D, Collinson P, Steptoe A. The association between cortisol response to mental stress and high-sensitivity cardiac troponin T plasma concentration in healthy adults. J Am Coll Cardiol 2013; 62: 1694-1701
  • 22 Güder G. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 2007; 115: 1754-1761
  • 23 Caldwell J, Jirikowski GF. Sex hormone binding globulin and corticosteroid binding globulin as major effectors of steroid action. Steroids 2014; 81: 13-16
  • 24 Talaber G, Boldizsar F, Bartis D, Palinkas L, Szabo M, Berta G, Setalo Jr G, Nemeth P, Berki T. Mitochondrial translocation of the glucocorticoid receptor in double-positive thymocytes correlates with their sensitivity to glucocorticoid-induced apoptosis. Int Immunol 2009; 21: 1269-1276
  • 25 Henley DE, Lightman SL. New insights into corticosteroid-binding globulin and glucocorticoid delivery. Neuroscience 2011; 180: 1-8
  • 26 Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 2008; 4: 525-533